Back to search results

Virtual Reality for Brachytherapy in Endocervical Cancer

This study is exploring if using a Virtual Reality (VR) headset, specifically the Oculus Quest 2, can make brachytherapy (a type of internal radiation therapy) more comfortable for patients with endocervical cancer. Researchers want to see if VR distraction helps with patient satisfaction, pain, and anxiety during treatment. They also want to understand if it's practical to use VR in a clinic setting. This study is for women aged 18 and older who need brachytherapy for gynecologic cancer. The study aims to enroll 20 participants.

Study design
This is a pilot study involving 20 participants. Each participant will receive four rounds of brachytherapy, with two rounds using VR distraction and two rounds without, in a randomized order.
What's involved
You would undergo four brachytherapy sessions. During these sessions, you would use the Oculus Quest 2 VR headset for two sessions and not use it for two sessions. You would also complete questionnaires about your satisfaction, pain, and anxiety.
Compensation
Not stated in the trial record.
Follow-up
Your satisfaction, pain, and anxiety will be measured at 3 weeks after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05440760

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Recruiting
NAAges 18+InterventionalSupportive care
University of Arkansas
~20 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:The Oculus Quest 2 Virtual Reality Headset

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The number of eligible subjects who enroll onto the study.
Measured over 3 weeks
+3 more outcomes measured

Conditions

Endocervical Cancer

Explore related trials

Cervical CarcinomaEndometrial CarcinomaVaginal CarcinomaVulvar Carcinoma

Where it's being run

1 sites across 1 states
Arkansas1

Study leadership

  • Santanu Samanta, MD · PRINCIPAL_INVESTIGATOR · University of Arkansas

Who to contact

Joseph A Holley
[email protected]
501-686-8274
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female, ≥ 18 years of age
Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy
Able to provide written consent

Exclusion

Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound
History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras
Known history of elevated intraocular pressure
Claustrophobia, thalassophobia, cleithrophobia or similar phobias
Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen

What this trial measures

  • The number of eligible subjects who enroll onto the study.3 weeks
  • The number of subjects who withdraw or are withdrawn from the study.3 weeks
  • The number of subjects who successfully complete the study questionnaires for satisfaction, procedural pain, and anxiety.3 weeks
  • The number of times a technical problem occurs with the VR distraction3 weeks